Connect with us

Health

Nigerian professor finally writes NAFDAC to treat COVID-19 patients for free

Published

on

Adeleye also promised to carry out the treatment of the 10 persons free of charge in any of the facilities nationwide to authenticate the efficacy of his therapy.

ROYAL NEWS reports that the varsity don, a Kaduna based researcher stated this in a letter sent to the National Agency for Food and Drug Administration and Control (NAFDAC) through the Kaduna State coordinator in respect of his coronavirus research findings in the capital.

Adeleye said: “My cure research on the COVID-19 pandemic resulted in the production of the virus killer herbal medicine, which I am submitting to expedite action for those affected as quickly as possible in order to reduce the death rates and also save lives.

“The drug has been fully labelled as attached. Information for its awareness and other researches is attached. The drug acts fast, requiring only one wine glass dosage, and the patient is healed and may test negative from the second day onward.

“The drug gives protection (immunity) from further infection. Uninfected persons will also enjoy the same immunity and protection after taking it. There is no side effect whatsoever for user of the drug.”

He further stressed that, “It removed blockage of the lungs that allows patient to breath freely. No ventilator is required after one wine glass treatment. I intend to treat five patients already on ventilator and five positive persons free of charge.

“I intend to treat directly five patients that are positive without any protective gadget or jacket, and under the scrutiny of the media, especially television camera.”

Facebook Comments Box

DOWNLOAD ROYAL NEWS eCOPY March 28, 2022


Copyright 2022 ROYAL NEWS. All rights reserved. Digital material on this website, may not be published, reproduced, broadcast, rewritten or redistributed in whole or in part without prior express written permission from ROYAL NEWS.

Contact: info@royalnews.com.ng

Download ROYAL NEWS app

Advertisement
Click to comment

Leave a Reply

Your email address will not be published.